Lotta Ljung

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Anja Strangfeld, Martin Schäfer, Milena Gianfrancesco et al. · Annals of the Rheumatic Diseases · 2021 · 691 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +8

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Ronald van Vollenhoven, Sofia Ernestam, P. Geborek et al. · The Lancet · 2009 · 317 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

Lena Innala, Bozena Möller, Lotta Ljung et al. · Arthritis Research & Therapy · 2011 · 232 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study

Lena Innala, Ewa Berglin, Bozena Möller et al. · Arthritis Research & Therapy · 2014 · 170 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still’s Disease. An Open, Randomized, Multicenter Study

Dan Nordström, Ann Knight, Reijo Luukkainen et al. · The Journal of Rheumatology · 2012 · 163 citations · Full text

Medicine, Immunology, Pharmacotherapy +17